Analysis: Just 28% of countries have released nature pledges a year after UN deadline
Just 28% of countries have met a UN call to submit new plans on addressing nature loss –…
Majority of Carbon Credits From Tarnished Project Deemed Bogus
After a two-year probe, the world’s largest certifier of carbon offsets has determined that most of the credits…
Social Security COLA increase still uncertain after shutdown. Here’s why
Social Security trust fund projected to run dry in less than 10 years The main trust fund used…
Immigration crackdown likely contributing to weak Texas job growth
Isabel Brizuela, Emily Kerr, Pia Orrenius and Madeline Zavodny Immigration into Texas from outside the country has slowed…
When is the Social Security 2026 COLA announcement date?
Social Security checks increasing in 2025 The Cost of Living Adjustment is rising in 2025, which will change…
Fed’s Williams Is Watching Job Market, Backs More Rate Cuts
Federal Reserve Bank of New York President John Williams backed additional interest-rate cuts this year and said he…
Welcome to the ‘papers, please’ internet
This is The Stepback, a weekly newsletter breaking down one essential story from the tech world. For more…
Egypt Gets S&P Upgrade in Latest Sign of Economic Turnaround
S&P Ratings lifted Egypt’s credit rating, citing policy changes that have improved the economic outlook, giving a further…
Brendan Carr wants to let internet providers charge hidden fees again
Broadband customers may find themselves blighted by unexpected charges again, thanks to Federal Communications Commission chairman Brendan Carr.…
Google fights to prevent search remedies from inhibiting its AI ambitions
A court order will require Google to scale back some of its more aggressive tactics to get its…
Analysis | How can policy-makers boost the health and employment of working age people?
What factors are driving up employee absence? The report provides important data about the immediate causes of sickness…
Coverage of Sarepta Duchenne drug may be halted by N.Y. state Medicaid
In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid…